St Phi Therapeutics

About:

Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies.

Website: http://www.stphitherapeutics.com

Top Investors: Shenzhen Capital Group, Tao Capital Partners, Panacea Venture, Tailong Investment, Tasly Capital

Description:

Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy.

Total Funding Amount:

100M CNY

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2017-01-01

Contact Email:

izun(AT)stphibio.com

Founders:

Number of Employees:

Last Funding Date:

2024-04-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai